Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
852A in unresectable metastatic cutaneous melanoma
NCT00189332Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of 852A in cutaneous melanoma (CM), sponsored by Pfizer. Started Feb 2005; status: completed.
02
Drugs
852A
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT00189332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189332.